202 related articles for article (PubMed ID: 3463397)
1. Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia.
Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Smith TL; Talpaz M; Beran M; Cork A; Trujillo JM; Freireich EJ
Cancer; 1986 Nov; 58(9):2023-30. PubMed ID: 3463397
[TBL] [Abstract][Full Text] [Related]
2. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival.
Kantarjian HM; Smith TL; McCredie KB; Keating MJ; Walters RS; Talpaz M; Hester JP; Bligham G; Gehan E; Freireich EJ
Blood; 1985 Dec; 66(6):1326-35. PubMed ID: 3864497
[TBL] [Abstract][Full Text] [Related]
3. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
Kantarjian HM; Keating MJ; Talpaz M; Walters RS; Smith TL; Cork A; McCredie KB; Freireich EJ
Am J Med; 1987 Sep; 83(3):445-54. PubMed ID: 3477958
[TBL] [Abstract][Full Text] [Related]
4. Clinical investigation of human alpha interferon in chronic myelogenous leukemia.
Talpaz M; Kantarjian HM; McCredie KB; Keating MJ; Trujillo J; Gutterman J
Blood; 1987 May; 69(5):1280-8. PubMed ID: 3471281
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of prognostic factors in Philadelphia chromosome positive chronic myeloid leukemia: an update of the first series in Thailand.
Jootar S; Ungkanont A; Chuncharunee S; Atichartakarn V
Asian Pac J Allergy Immunol; 1996 Jun; 14(1):25-30. PubMed ID: 8980797
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic features of patients with Philadelphia chromosome-positive chronic myelogenous leukemia and extramedullary disease.
Terjanian T; Kantarjian H; Keating M; Talpaz M; McCredie K; Freireich EJ
Cancer; 1987 Jan; 59(2):297-300. PubMed ID: 3467820
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome.
Stoll DB; Peterson P; Exten R; Laszlo J; Pisciotta AV; Ellis JT; White P; Vaidya K; Bozdech M; Murphy S
Am J Hematol; 1988 Feb; 27(2):77-83. PubMed ID: 3422539
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetics of chronic myelogenous leukemia (CML) correlated to the histopathology of bone marrow biopsies.
Werner M; Kaloutsi V; Buhr T; Delventhal S; Vykoupil KF; Georgii A
Ann Hematol; 1991 Oct; 63(4):201-5. PubMed ID: 1932298
[TBL] [Abstract][Full Text] [Related]
10. Transformation of chronic myelogenous leukemia: clinical, morphologic, and cytogenetic features.
Muehleck SD; McKenna RW; Arthur DC; Parkin JL; Brunning RD
Am J Clin Pathol; 1984 Jul; 82(1):1-14. PubMed ID: 6588747
[TBL] [Abstract][Full Text] [Related]
11. Significance of cytogenetic clonal evolution in chronic myelogenous leukemia.
Majlis A; Smith TL; Talpaz M; O'Brien S; Rios MB; Kantarjian HM
J Clin Oncol; 1996 Jan; 14(1):196-203. PubMed ID: 8558198
[TBL] [Abstract][Full Text] [Related]
12. Terminal-phase chronic myelogenous leukemia: approaches to treatment.
Allen SL; Coleman M
Cancer Invest; 1985; 3(5):491-503. PubMed ID: 3902166
[TBL] [Abstract][Full Text] [Related]
13. Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia.
Kantarjian HM; Vellekoop L; McCredie KB; Keating MJ; Hester J; Smith T; Barlogie B; Trujillo J; Freireich EJ
J Clin Oncol; 1985 Feb; 3(2):192-200. PubMed ID: 3855444
[TBL] [Abstract][Full Text] [Related]
14. Blast crisis of Philadelphia chromosome-positive chronic myelocytic leukemia (CML). Treatment results of 69 patients.
Anger B; Carbonell F; Braunger I; Heinze B; Gutensohn W; Thiel E; Heimpel H
Blut; 1988 Sep; 57(3):131-7. PubMed ID: 3166389
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic studies in blast crisis of Ph-positive chronic granulocytic leukemia: results and prognostic evaluation in 52 patients.
Cervantes F; Ballesta F; Mila M; Rozman C
Cancer Genet Cytogenet; 1986 Apr; 21(3):239-46. PubMed ID: 3456263
[TBL] [Abstract][Full Text] [Related]
16. Philadelphia chromosome-positive chronic myelocytic leukemia in children. Survival and prognostic factors.
Castro-Malaspina H; Schaison G; Briere J; Passe S; Briere J; Pasquier A; Tanzer J; Jacquillat C; Bernard J
Cancer; 1983 Aug; 52(4):721-7. PubMed ID: 6574807
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
18. Evolution of karyotypes in Philadelphia (Ph1) chromosome-negative chronic myelogenous leukemia.
Mintz U; Vardiman J; Golomb HM; Rowley JD
Cancer; 1979 Feb; 43(2):411-6. PubMed ID: 283874
[TBL] [Abstract][Full Text] [Related]
19. Prognostic features at diagnosis of chronic myelocytic leukemia.
Gomez GA; Sokal JE; Walsh D
Cancer; 1981 May; 47(10):2470-7. PubMed ID: 6944141
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
